Sixth Issue, Series Two - Uncategorized
In April 2011, the National Comprehensive Cancer Network (NCCN) convened a summit of key stakeholders regarding the issues surrounding biosimilars in oncology care. The working group subsequently published a sentinel white paper outlining the regulatory, scientific, and patient safety issues surrounding the development and expansion of biosimilars in oncology care.1 [ Read More ]
Fifth Issue, Series Two - Uncategorized
In 2005, the Institute of Medicine released a report with a title that became a wake-up call for many in the field of oncology, From Cancer Patient to Cancer Survivor: Lost in Transition. A committee of 17 experts in the field set out to raise awareness of the consequences of [ Read More ]
Fourth Issue, Series Two - Uncategorized
In this issue of Conquering the Cancer Care Continuum, Ms Faiman and Dr Stricker focus on aspects of treatment planning in cancer patients. While they come at the topic from slightly different angles, both cases illustrate that deciding on whether to treat patients, which drugs to use, and what other [ Read More ]
Third Issue, Series Two - Uncategorized
Each year in the United States, over 1.5 million people are diagnosed with cancer and nearly 600,000 will die of cancer. While cure rates for certain cancers have increased over the decades and survival has lengthened for many incurable cancers, ultimately the vast majority of patients with metastatic disease from [ Read More ]
Second Issue, Series Two - Uncategorized
Pain management is a critical component of patient care in any medical specialty, but particularly in oncology. The 2 case presentations and discussions by Beth Faiman and Steve Stricker are common cases in which pain management is integral to the overall care of the patient. As a medical oncologist specializing [ Read More ]
Copyright 2023. The Lynx Group, LLC. All Rights Reserved. Privacy Policy. Sitemap.
